JXJT yields 247.68% · JNJ yields 2.13%● Live data
📍 JXJT pulled ahead of the other in Year 1
Combined, JXJT + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of JXJT + JNJ for your $10,000?
JX Luxventure Limited, a casual menswear company, designs, develops, markets, and sells fashion menswear products in the People's Republic of China. The company operates through five segments: Wholesale, Retail, Contract Manufacturing, Tourism Service, and Cross-Border E-Commerce. It offers apparel products, including cotton and down jackets, sweaters, suits, shirts, T-shirts, jeans, and trousers; accessories, such as shoes, bags, belts, socks, and caps; and footwear for urban males between the ages of 20 and 40. As of December 31, 2021, the company owned and operated 1 corporate store and 29 franchised stores. It also provides packaged group tour services online through the Luxventure platform; and engages in the offline wholesale of health care, personal care, cosmetics, maternal and child, pet-related, and universal cuisine and household products, as well as online. In addition, the company offers tourism and selling carrier services. The company was formerly known as KBS Fashion Group Limited and changed its name to JX Luxventure Limited in October 2021. JX Luxventure Limited is headquartered in Haikou, the People's Republic of China.
Full JXJT Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.